In its efforts to police fraud, abuse, and misuse of opioids, the Office of the Inspector General (OIG), a division of the US Department of Health & Human Services, has focused on prescriptions for these extremely high-profile drugs obtained under Medicare Part D, the drug benefit for Medicare recipients. OIG issued a data brief in July 2017 titled Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing.
The 10 questions in the slides above are based on the report. Some of the questions may not challenge what you know, but we think you’ll be surprised by the answers to others. Good luck!
For more information, check out the full report: Office of Inspector General, US Dept of Health & Human Services. Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing. Washington, DC: US Dept of Health and Human Services. 2017. HHS OIG Data Brief OEI-02-17-00250